News

The British Pound (GBP) remains under pressure against the US Dollar (USD) on Tuesday, with GBP/USD falling to its lowest level since April 11 amid broad-based Greenback strength and growing fiscal concerns in the United Kingdom (UK).

Wall Street analysts raised concerns about Palantir’s elevated valuation and famed hedge fund manager Michael Burry revealed a short position.

The rise of Zohran Mamdani, a democratic socialist, has fueled a wave of spending to oppose his candidacy and back the former New York Gov. Andrew Cuomo.

Five months after Scale AI’s high-profile founder was hired by Meta, the startup is trying to show that it’s still on a growth trajectory.

The AUDUSD has trended lower today, extending its recent decline despite a less dovish, more hawkish tone from the Reserve Bank of Australia, which left interest rates unchanged. The move lower was primarily driven by technical factors, as the pair continued to weaken after failing to sustain a break above key support levels. Yesterday, the price briefly dipped below the 100-day moving average, only to close right back near it — showing initial hesitation from traders. However, in early Asian trading today, the pair broke decisively below that 100-day MA and held beneath it, giving sellers renewed control.

The downside momentum accelerated after breaking below yesterday’s low near 0.6519, and sellers pushed further through a swing area between 0.6500 and 0.65046.

In the U.S. session, the pair extended the move lower toward another target zone between 0.6478 and 0.64817, where support buyers finally stepped in, prompting a modest rebound back toward the 0.6500 area. That bounce, however, leaves a key question heading into the next session: Can buyers build momentum back above 0.6500, or will that level now act as resistance, keeping sellers in control for another test of the lower swing-area support?

This article was written by Greg Michalowski at investinglive.com.

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.

S&P 500 held up reasonably well during the regular session, but started to drift lower right after the closing bell – ES 6,850 area didn‘t hold, and selling quickly snowballed.